Printer Friendly
The Free Library
4,546,861 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

BancBoston Robertson Stephens Initiates Coverage of VGIN with a Buy Rating.


SAN FRANCISCO--(BUSINESS WIRE)--Sept. 15, 1999--

BancBoston Robertson Stephens senior biotechnology analyst Michael G. King Jr. today initiated coverage of Visible Genetics (NASDAQ:VGIN VGIN - Virginia Geographic Information Network) with a Buy rating.

Visible Genetics is a leader in HIV genotyping, having developed the TruGene(TM) HIV-1 Assay to determine virus genotype and thus better understand the patient's resistance profile to more effectively prescribe Highly-Active Anti-Retroviral Therapy (HAART).

"We are initiating coverage of Visible Genetics with a Buy rating," said King. "We view the market opportunity for HIV genotyping as large, based on Roche's Amplicor Viral Load assay, which is used more than two million times per year in North America. In our view, the TruGene HIV assay could become a standard of care, serving as a valuable diagnostic tool in the management of HIV."

"Visible Genetics' comp group is trading at 14.5 times the last-twelve-months revenues," said King. "We have therefore set a 12-month price target for the company of $32, by applying a 12 times multiple to our 2000 revenue forecast of $35 million."

Clients interested in receiving more information should contact their salesperson at 415/781-9700.

BancBoston Robertson Stephens is the leading full-service investment bank focused exclusively on growth companies. For the first half of 1999, the firm completed over 100 offerings, raising more than $15 billion in capital for clients and is the leading investment bank for Internet M&A transactions. The firm's 45 research analysts cover nearly 700 companies.

Founded in 1978, BancBoston Robertson Stephens is the section 20 subsidiary of BankBoston Corporation (NYSE:BKB). Together, BancBoston Robertson Stephens, BancBoston Robertson Stephens International, and Evergreen Securities Ltd. employ 1,000 employees throughout the world with offices in Boston, San Francisco, New York, Menlo Park, Chicago, London, and Tel Aviv.

For more information about the firm, please visit our Web site at www.rsco.com.

The following synopsis is qualified in its entirety by the more detailed information contained in the full research report, including the discussion of certain risks associated with an investment in this security contained in "Investment Risks."

The information contained herein is not a complete analysis of every material fact respecting any company, industry or security. Although opinions and estimates expressed herein reflect the current judgment of BancBoston Robertson Stephens, the information upon which such opinions and estimates are based is not necessarily updated on a regular basis; when it is, the date of the change in estimate will be noted.

In addition, opinions and estimates are subject to change without notice. This Report contains forward-looking statements, which involve risks and uncertainties. Actual results may differ significantly from the results described in the forward-looking statements. Factors that might cause such a difference include, but are not limited to, those discussed in "Investment Risks."

BancBoston Robertson Stephens from time to time performs corporate finance or other services for some companies described herein and may occasionally possess material, nonpublic information regarding such companies. This information is not used in the preparation of the opinions and estimates herein.

While the information contained in this Report and the opinions contained herein are based on sources believed to be reliable, BancBoston Robertson Stephens has not independently verified the facts, assumptions and estimates contained in this Report.

Accordingly, no representation or warranty, expressed or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information and opinions contained in this Report.

BancBoston Robertson Stephens, its managing directors, its affiliates, and/or its employees may have an interest in the securities of the issue(s) described and may make purchases or sales while this report is in circulation. BancBoston Robertson Stephens International Ltd. is regulated by the Securities and Futures Authority in the United Kingdom.

This publication is not meant for private customers. The securities discussed herein are not FDIC insured, are not deposits or other obligations or guarantees of BankBoston N.A., and are subject to investment risk, including possible loss of any principal amount invested.
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 15, 1999
Words:665
Previous Article:OpenService and Nokia Partner to Enhance Management of Secure Communications Devices.
Next Article:Merger Between LVIP and Player's Choice Creates Online Golf and Travel Leader.
Topics:



Related Articles
BancBoston Robertson Stephens Initiates Coverage of HOTJ with a Buy Rating.
BancBoston Robertson Stephens Initiates Coverage of QSFT with a Buy Rating.
BancBoston Robertson Stephens Initiates Coverage of the Hotel REIT Industry, MHX with a Buy Rating, FCH and KPA with Long-Term Attractive Ratings.
BancBoston Robertson Stephens Initiates Coverage of SSSW with a Buy Rating.
BancBoston Robertson Stephens Initiates Coverage of NTRO with a Buy Rating.
BancBoston Robertson Stephens Initiates Coverage of MYPT with a Buy Rating.
BancBoston Robertson Stephens Initiates Coverage of BSX with a Buy Rating.
BancBoston Robertson Stephens Initiates Coverage of the B2B eCommerce Sector, With Buy Ratings on CMDX, ICGE, VERT.
BancBoston Robertson Stephens Initiates Coverage of CACS with a Buy Rating.
Robertson Stephens Initiates Coverage of EXAR with a Buy Rating.

Terms of use | Copyright © 2008 Farlex, Inc. | Feedback | For webmasters | Submit articles